Roche's 2011 MDx Sales Rise 4 Percent as Applied Science Lags | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche today reported 2011 revenue growth of 6 percent at constant exchange rates for its diagnostics division including a 4 percent increase in sales for molecular diagnostic products.

The Swiss drugs, diagnostics, and research products giant reported total diagnostics sales of CHF 9.74 billion ($10.65 billion). Though the firm reported growth at constant exchange rates, in Swiss francs its diagnostics sales were down 7 percent from CHF 10.42 billion a year ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.